Journal article Published 2018
Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells
Molecular Oncology 12(4), 561-576 (2018)
- 2018 Year
- 29465803 PMID
Cite this publication
FEIERSINGER, G., K. TRATTNIG, P. LEITNER, F. GUGGENBERGER, A. OBERHUBER, S. PEER, M. HERMANN, I. SKVORTSOVA, J. VRBKOVÁ, J. BOUCHAL, Z. CULIG, F. SANTER: Olaparib is effective in combination with, and as maintenance therapy after, first-line endocrine therapy in prostate cancer cells. Molecular Oncology. 2018, 12(4), 561-576, ISSN: 1574-7891, PMID: 29465803.
Details
- ISSN
- 1574-7891
